Compile Data Set for Download or QSAR
Report error Found 228 Enz. Inhib. hit(s) with all data for entry = 9995
TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506557BDBM506557(US11045457, Example 157)
Affinity DataIC50: 1.58nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506586BDBM506586(US11045457, Example 187)
Affinity DataIC50: 3.98nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506515BDBM506515(US11045457, Example 115)
Affinity DataIC50: 5.01nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506558BDBM506558(US11045457, Example 158)
Affinity DataIC50: 7.94nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506544BDBM506544(US11045457, Example 144)
Affinity DataIC50: 10nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506504BDBM506504(US11045457, Example 104)
Affinity DataIC50: 10nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506430BDBM506430(US11045457, Example 30)
Affinity DataIC50: 15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506502BDBM506502(US11045457, Example 102)
Affinity DataIC50: 15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506510BDBM506510(US11045457, Example 145 | US11045457, Example 110)
Affinity DataIC50: 15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506507BDBM506507(US11045457, Example 107)
Affinity DataIC50: 20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506561BDBM506561(US11045457, Example 161)
Affinity DataIC50: 20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506615BDBM506615(US11045457, Example 216)
Affinity DataIC50: 20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506593BDBM506593(US11045457, Example 194)
Affinity DataIC50: 20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506428BDBM506428(US11045457, Example 28)
Affinity DataIC50: 20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506608BDBM506608(US11045457, Example 209)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506587BDBM506587(US11045457, Example 188)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506609BDBM506609(US11045457, Example 210)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506589BDBM506589(US11045457, Example 190)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506470BDBM506470(US11045457, Example 70)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506606BDBM506606(US11045457, Example 207)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506427BDBM506427(US11045457, Example 27)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506612BDBM506612(US11045457, Example 213)
Affinity DataIC50: 25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506595BDBM506595(US11045457, Example 196)
Affinity DataIC50: 31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506413BDBM506413(US11045457, Example 13 | BDBM506508)
Affinity DataIC50: 31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506547BDBM506547(US11045457, Example 147)
Affinity DataIC50: 31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506429BDBM506429(US11045457, Example 29)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506566BDBM506566(US11045457, Example 166)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506611BDBM506611(US11045457, Example 212)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506524BDBM506524(US11045457, Example 124)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506548BDBM506548(US11045457, Example 148)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506579BDBM506579(US11045457, Example 179)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506585BDBM506585(US11045457, Example 186)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506467BDBM506467(US11045457, Example 67)
Affinity DataIC50: 39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506426BDBM506426(US11045457, Example 26)
Affinity DataIC50: 50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506471BDBM506471(US11045457, Example 71)
Affinity DataIC50: 50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506525BDBM506525(US11045457, Example 125)
Affinity DataIC50: 50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506550BDBM506550(US11045457, Example 150)
Affinity DataIC50: 50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506519BDBM506519(US11045457, Example 119)
Affinity DataIC50: 50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506528BDBM506528(US11045457, Example 128)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506538BDBM506538(US11045457, Example 138)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506469BDBM506469(US11045457, Example 69)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506610BDBM506610(US11045457, Example 211)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506420BDBM506420(US11045457, Example 20)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506523BDBM506523(US11045457, Example 123)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506539BDBM506539(US11045457, Example 177 | US11045457, Example 139)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506555BDBM506555(US11045457, Example 155)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506416BDBM506416(US11045457, Example 16)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506505BDBM506505(US11045457, Example 105)
Affinity DataIC50: 63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506536BDBM506536(US11045457, Example 152 | US11045457, Example 136)
Affinity DataIC50: 79.4nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 506527BDBM506527(US11045457, Example 127)
Affinity DataIC50: 79.4nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Displayed 1 to 50 (of 228 total ) | Next | Last >>
Jump to: